Marshall Wace Asia’s Cardinal Health CAH Stock Holding History

Marshall Wace Asia’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,751	Closed	-$1.07M	–	158
2020 Q3	$1.07M	Buy	+22,751	New	+$1.17M	0.02%	108

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace Asia's CAH Position: Q4 2020 in Review

Marshall Wace Asia sold out of Cardinal Health (CAH) in Q4 2020, closing a stake of 22,751 shares — an estimated $1.07M sold.

Marshall Wace Asia first reported a position in CAH in Q3 2020 and held it in 1 quarter. The position peaked at $1.07M in Q3 2020. 781 funds tracked by Wall St. Rank hold CAH as of Q4 2020.

Marshall Wace Asia reported no remaining Cardinal Health position as of Q4 2020 after selling out during the quarter.
Marshall Wace Asia sold 22,751 Cardinal Health shares in Q4 2020, an estimated $1.07M.
Marshall Wace Asia first reported a position in Cardinal Health in Q3 2020 and held it in 1 quarter.
Marshall Wace Asia's Cardinal Health position peaked at $1.07M in Q3 2020.
781 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2020.

Based on Marshall Wace Asia's 13F filing for Q4 2020, filed 16 Feb 2021.